Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
43.72
-0.06 (-0.14%)
At close: Aug 14, 2026, 4:00 PM EDT
43.83
+0.11 (0.25%)
After-hours: Aug 14, 2026, 7:30 PM EDT
Sanofi Market Cap
Sanofi has a market cap or net worth of $104.76 billion as of August 14, 2026. Its market cap has decreased by -14.92% in one year.
Market Cap
104.76B
Enterprise Value
125.12B
1-Year Change
-14.92%
Ranking
Category
Stock Price
$43.72
ChartMarket Cap Chart
Since July 1, 2002, Sanofi's market cap has increased from $43.61B to $104.76B, an increase of 140.24%. That is a compound annual growth rate of 3.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 106.63B | -12.90% |
| Dec 31, 2025 | 122.42B | 0.34% |
| Dec 31, 2024 | 122.00B | -1.86% |
| Dec 29, 2023 | 124.32B | 1.57% |
| Dec 30, 2022 | 122.39B | -3.12% |
| Dec 31, 2021 | 126.33B | 3.68% |
| Dec 31, 2020 | 121.85B | -2.56% |
| Dec 31, 2019 | 125.04B | 14.85% |
| Dec 31, 2018 | 108.87B | -2.02% |
| Dec 29, 2017 | 111.11B | 5.22% |
| Dec 30, 2016 | 105.60B | -6.16% |
| Dec 31, 2015 | 112.54B | -6.84% |
| Dec 31, 2014 | 120.80B | -16.01% |
| Dec 31, 2013 | 143.83B | 13.19% |
| Dec 31, 2012 | 127.07B | 32.63% |
| Dec 30, 2011 | 95.81B | 12.73% |
| Dec 31, 2010 | 84.99B | -17.74% |
| Dec 31, 2009 | 103.32B | 17.60% |
| Dec 31, 2008 | 87.86B | -29.03% |
| Dec 31, 2007 | 123.79B | -4.33% |
| Dec 29, 2006 | 129.40B | 4.42% |
| Dec 30, 2005 | 123.92B | 111.11% |
| Dec 31, 2004 | 58.70B | 6.16% |
| Dec 31, 2003 | 55.29B | 24.18% |
| Dec 31, 2002 | 44.53B | 2.12% |
View and export this data all the way back to 2002. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AbbVie | 443.23B |
| Merck & Co. | 334.43B |
| Novartis AG | 289.45B |
| AstraZeneca | 245.10B |
| Amgen | 225.90B |
| Novo Nordisk | 203.52B |
| Gilead Sciences | 171.29B |
| Pfizer | 152.75B |